Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Liminal BioSciences Inc. PFSCF


Primary Symbol: LMNL

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.


NDAQ:LMNL - Post by User

Bullboard Posts
Comment by eric40on Feb 22, 2018 9:34pm
179 Views
Post# 27606668

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:My take on the current low pps

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:My take on the current low ppsTo KenLu1, It takes so long for many reasons. One of them was actually fully discussed and is related to the many hundreds extra documents presented for the PRV. the second one is related to Oncle Donald. With the election in the USA, there was a big reorganisation at the FDA. New president of FDA, new seats, new orientations and the person in charge at the FDA for the plasminogene trial of Prometic was replace by a new one who was new to the whole process. So the learning curve by this new person in charge of Prometic file made the process much longer than it was suppose to be. This situation is out of the control of Prometic.

However , the 14 of april is the FDA deadline and is 36 trading days away now.
Bullboard Posts